Researches molecules to PREvent and treat high blood sugar levels
Glycemicon has raised €99k across 1 funding round, most recently a Seed round in Jan 2013. Based in Schwerzenbach, Switzerland; active in Foodtech and Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2013-01-01 | Seed | €99k |
| — |
| View deal → |
